208 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hyperlipidemias"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Conditions: Chronic Smokers;   Hyperlipidemia
Interventions: Other: Placebo;   Dietary Supplement: BioTurmin (Curcuma longa rhizomes extract);   Dietary Supplement: BioTurmin-WD (Water dispersible curcuminoids);   Dietary Supplement: MaQxan (Tagetes erecta flower extract)
2 Recruiting Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Conditions: Essential Hypertension;   Hyperlipidemia
Interventions: Drug: Atorvastatin;   Drug: Losartan;   Drug: Placebo;   Drug: HL-040XC
3 Not yet recruiting Randomized Clinical Trial of RN316 (PF-04950615) inSubjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events.
Condition: Hyperlipidemia
Interventions: Drug: PF-04950615;   Other: Placebo
4 Available Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: rosuvastatin,fenofibrate;   Genetic: CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP
5 Recruiting Telemedicine Based Management of Hyperlipidemia
Condition: Hyperlipidemia
Intervention: Device: Self Monitoring Lipid Analyzer
6 Recruiting Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Conditions: Hypertension;   Hyperlipidemia
Interventions: Drug: Telmisartan 80mg;   Drug: Rosuvastatin 20mg;   Drug: Rosuvastatin 10mg;   Drug: Placebo(for Telmisartan 80mg);   Drug: Placebo(for Rosuvastatin 20mg);   Drug: Placebo(for Rosuvastatin 10mg)
7 Unknown  Jiangzhuo Prescription ,Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
Conditions: Metabolic Syndromes;   Hyperlipidemia
8 Unknown  Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
Conditions: HIV;   Hyperlipidemia;   HIV Infections
Interventions: Drug: ezetimibe;   Drug: fenofibrate;   Drug: pravastatin
9 Recruiting Randomized Clinical Trial Of RN316 (PF-04950615) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: PF-04950615;   Other: Placebo
10 Recruiting Randomized Clinical Trial of RN316 (PF-04950615) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: PF-04950615;   Other: Placebo
11 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
12 Recruiting Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg;   Drug: atorvastatin 20mg
13 Recruiting Randomized Clinical Trial of RN316 (PF-04950615) in Subjects Who Are Intolerant to Statins
Condition: Hyperlipidemia
Interventions: Drug: PF-04950615;   Drug: Atorvastatin;   Other: Placebo for PF-04950615;   Other: Placebo for atorvastatin
14 Recruiting Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy
Condition: Hyperlipidemias
Interventions: Drug: HMGCoA reductase inhibitor;   Drug: HMGCoA reductase inhibitor + probucol;   Drug: HMGCA reductase inhibitor + probucol + cilostazol
15 Unknown  The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles
Condition: Hyperlipidemia
Intervention: Drug: Lipid-lowing Tea
16 Unknown  Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
Conditions: Hyperlipidemia;   Coronary Artery Disease
Intervention: Drug: Rosuvastatin
17 Recruiting A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Conditions: Hypertriglyceridemia;   Mixed Hyperlipidemia
Interventions: Drug: TRIA-662;   Drug: Placebo
18 Unknown  The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians
Conditions: Hypertension;   Hyperlipidemia
Intervention: Behavioral: Free Generic Samples (hydrochlorothiazide, simvastatin)
19 Recruiting Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
Conditions: Nephrotic Syndrome;   Hyperlipidemia
Intervention: Drug: Pravastatin
20 Not yet recruiting Improving Heart Health in Appalachia
Conditions: Obesity;   Hypertension;   Hyperlipidemia;   Depression
Interventions: Behavioral: patient-centered, culturally appropriate, self-care CVD risk reduction;   Other: Referral to primary care provider for CVD risk management

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years